Streetbeat News

Earnings

BDRX

BGLC

IMPL

PRQR

RDHL

SHOP

THAR

U.S. stocks opened lower on Monday, with the Dow Jones down by over 50 points. Shopify Inc (SHOP) reported a record $4.1 billion in Black Friday sales, a 22% increase from last year. RedHill Biopharma (RDHL), Biodexa Pharmaceuticals (BDRX), and Tharimmune (THAR) saw their stocks surge on positive news, while BioNexus Gene Lab (BGLC), Impel Pharmaceuticals (IMPL), and ProQR Therapeutics (PRQR) experienced declines. Oil prices dipped slightly, while gold and silver saw gains.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 2:46 pm

THAR

Tharimmune shares have seen an increase in trading activity following the announcement of positive Phase 1 data for their drug TH104. This development could potentially lead to further clinical trials and advancements in the company's pipeline, attracting investor interest.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 2:46 pm

GDC

LIZI

MOMO

TEO

Benzinga Insights has identified five value stocks in the communication services sector based on their low P/E ratios, suggesting they may be undervalued. The stocks are GD Culture Group (GDC), Lizhi (LIZI), Scienjoy Holding (SJ), Telecom Argentina (TEO), and Hello Gr (MOMO). The article provides recent earnings per share (EPS) data, indicating mixed performance with some companies experiencing decreases in EPS while others have seen increases.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 2:44 pm

FWBI

KPRX

OGN

TXMD

VYGR

Benzinga Insights has identified notable value stocks in the healthcare sector based on low P/E multiples. First Wave BioPharma (FWBI), Kiora Pharmaceuticals (KPRX), TherapeuticsMD (TXMD), Voyager Therapeutics (VYGR), and Organon (OGN) are highlighted as undervalued. FWBI, KPRX, and VYGR reported decreased earnings per share in their latest quarters, while TXMD saw an increase, and OGN experienced a decrease but also reported a higher dividend yield.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 2:43 pm

Smart Share Global Ltd (NASDAQ:EM) reported a 24.7% year-on-year decline in Q3 FY23 sales to $84.08 million, primarily due to a decrease in mobile device charging revenues. The company's mobile device charging revenues fell 30.3% to $77.3 million. General and administrative expenses increased by 26.1% to $5.1 million, while operating income was $4.7 million. Smart Share Global had $455.0 million in cash and equivalents and saw an increase in service availability and registered users. However, adjusted earnings per ADS of $0.03 missed the consensus estimate of $0.10, and shares traded lower by 0.65% at $0.7450.

Portfolio Pulse from Shivani Kumaresan

November 27, 2023 | 2:39 pm

AFCG

ARL

FBRT

RITM

The article provides an overview of notable value stocks in the real estate sector, focusing on companies with low P/E multiples, indicating potential undervaluation. AFC Gamma (AFCG), American Realty Investors (ARL), Ready Capital (RC), Rithm Capital (RITM), and Franklin BSP Realty Trust (FBRT) are highlighted as value stocks. The article includes their P/E ratios, EPS, and dividend yields, noting changes from the previous quarter. It cautions that value stocks may take time to rebound and there's a risk they may not.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 2:39 pm

PSHG

Performance Shipping reported Q3 earnings with an EPS of $0.27, missing the sales estimate of $27.30M with actual sales of $24.10M.

Portfolio Pulse from Bill Haddad

November 27, 2023 | 2:32 pm

REGN

SNY

Regeneron Pharmaceuticals Inc and Sanofi SA announced positive results from the second Phase 3 trial (NOTUS) of Dupixent for treating COPD, showing significant reduction in exacerbations and improvements in lung function. The EMA is reviewing Dupixent for COPD, and the companies plan to submit trial data to the FDA by year-end. Interim analysis results will be the primary analysis for the trial. Sanofi also plans to spin off its consumer healthcare business to focus on innovative medicines and vaccines. REGN shares closed at $798.30, and SNY stock is up 0.89% at $47.60 in premarket trading.

Portfolio Pulse from Vandana Singh

November 27, 2023 | 2:17 pm

CRNC

Cerence Inc. reported mixed financial results for Q4, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 2:14 pm

CAN

Canaan Inc. (NASDAQ:CAN) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-28. Analysts predict an EPS of $-0.26. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Canaan's stock price has been sensitive to earnings performance and guidance. Last quarter, Canaan missed EPS estimates by $0.47, resulting in a 5.63% share price drop the following day. Over the past year, Canaan's shares have declined by 29.58%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 2:01 pm